Jeil Pharmaceutical Co Ltd (271980) — Financial Flexibility Index
Jeil Pharmaceutical Co Ltd (271980) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of ₩16.78 Billion (operating CF ₩13.23 Billion minus capex ₩3.55 Billion) represents 0% of total liabilities (₩258.07 Billion). Check 271980 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jeil Pharmaceutical Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Jeil Pharmaceutical Co Ltd across 8 annual periods. See 271980 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jeil Pharmaceutical Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Jeil Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Jeil Pharmaceutical Co Ltd (271980) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.03x | ₩9.83 Billion | ₩3.21 Billion | ₩306.38 Billion | ▲ +130.5% |
| 2023 | 0.01x | ₩4.60 Billion | ₩-4.98 Billion | ₩330.29 Billion | ▲ +131.4% |
| 2022 | 0.01x | ₩1.81 Billion | ₩-15.15 Billion | ₩301.29 Billion | ▼ -93.6% |
| 2021 | 0.09x | ₩24.44 Billion | ₩19.10 Billion | ₩259.14 Billion | ▲ +234.5% |
| 2020 | -0.07x | ₩-16.64 Billion | ₩-19.05 Billion | ₩237.18 Billion | ▼ -154.1% |
| 2019 | 0.13x | ₩30.04 Billion | ₩28.96 Billion | ₩231.54 Billion | ▼ -10.9% |
| 2018 | 0.15x | ₩31.74 Billion | ₩21.45 Billion | ₩217.97 Billion | ▲ +16350.6% |
| 2017 | 0.00x | ₩-211.24 Million | ₩-4.21 Billion | ₩235.74 Billion | — |